Evaluation of pharmacokinetic interaction between esomeprazole (40 mg) and acetylsalicylic acid (325 mg) in healthy volunteers

被引：0
|
作者：
Niazi, M. [1 ]
Andersson, T. [1 ]
Sundin, M. [1 ]
Naesdal, J. [1 ]
机构：
[1] Astrazeneca R&D, Molndal, Sweden
来源：
EUROPEAN HEART JOURNAL | 2008年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：608 / 609
页数：2
相关论文
共 50 条
  • [1] Evaluation of the pharmacokinetic interaction between esomeprazole (40 mg) and acetylsalicylic acid (325 mg) in healthy volunteers
    Niazi, M.
    Andersson, T.
    Naucler, E.
    Sundin, M.
    Naesdal, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (09) : 564 - 569
  • [2] Evaluation of bioequivalence between a single-capsule formulation of esomeprazole 40 mg and acetylsalicylic acid 325 mg and the monotherapies given separately in healthy volunteers
    Niazi, M.
    Andersson, T.
    Naucler, E.
    Naesdal, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (02) : 169 - 176
  • [3] Evaluation of the Pharmacodynamics of Acetylsalicylic Acid 81 mg With or Without Esomeprazole 20 mg in Healthy Volunteers
    Andersson, Tommy
    Morrison, Dennis
    Nagy, Peter
    Pisupati, Jaya
    Schettler, Jared
    Warner, Timothy D.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (04) : 217 - 224
  • [4] Evaluation of the Pharmacodynamics of Acetylsalicylic Acid 81 mg With or Without Esomeprazole 20 mg in Healthy Volunteers
    Tommy Andersson
    Dennis Morrison
    Péter Nagy
    Jaya Pisupati
    Jared Schettler
    Timothy D. Warner
    American Journal of Cardiovascular Drugs, 2012, 12 (4) : 217 - 224
  • [5] A Single Capsule Formulation of Esomeprazole 40 Mg and Acetylsalicylic Acid 325 Mg Compared with the Monotherapies Given Separately: A Single-Dose Bioequivalence Study in Healthy Subjects
    Niazi, Mohammad
    Naucler, Emma
    Naesdal, Jorgen
    GASTROENTEROLOGY, 2009, 136 (05) : A636 - A637
  • [6] Early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in Caucasian healthy volunteers
    Galmiche, JP
    des Varannes, SB
    Sacher-Huvelin, S
    Vavasseur, F
    Taccoen, A
    Fiorentini, P
    Homerin, M
    GASTROENTEROLOGY, 2004, 126 (04) : A334 - A334
  • [7] Rabeprazole 20 mg compared with esomeprazole 40 mg in the control of intragastric pH in healthy volunteers
    Baisley, K
    Warrington, S
    Tejura, B
    Morocutti, A
    Miller, N
    GUT, 2002, 50 : A63 - A63
  • [8] EVALUATION OF THE PHARMACOKINETIC INTERACTION BETWEEN RUPATADINE 10 MG AND MIDAZOLAM 7.5 MG, IN HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS
    Ballester, M. R.
    Puntes, M.
    Gich, I
    Coimbra, J.
    Martinez, J.
    Ferrero, J. M.
    Gonzalez, M.
    Martinez, M.
    Claramunt, J.
    Martinez, D.
    Garrido, M.
    Santamaria, E.
    Izquierdo, I. I.
    Antonijoan, R. M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 31 - 31
  • [9] Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers
    Wilder-Smith, CH
    Röhss, K
    Nilsson-Pieschl, C
    Junghard, O
    Nyman, L
    DIGESTION, 2003, 68 (04) : 184 - 188
  • [10] Rabeprazole 20 mg compared with esomeprazole 40 mg in the control of intragastric pH in healthy volunteers
    Baisley, K
    Warrington, S
    Tejura, B
    Morocutti, A
    Miller, N
    GASTROENTEROLOGY, 2002, 122 (04) : A199 - A199
12345